JD Health International, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

EC Healthcare

ADICON Holdings Ltd.

Perfect Medical Health Management Ltd.

C-MER Eye Care Holdings Ltd.

Jinxin Fertility Group Ltd.

MedSci Healthcare Holdings Ltd.

New Horizon Health Ltd.

Arrail Group Ltd.

JD Health International, Inc.

Yunkang Group Ltd.

ClouDr Group Ltd.

Why is JD Health International, Inc. ?

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Poor long term growth as Operating profit has grown by an annual rate 12.09% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 98.18%, its profits have risen by 59.8%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is JD Health International, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

JD Health International, Inc.

95.58%

2.73

49.93%

Hang Seng Hong Kong

27.36%

1.03

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

25.17%

EBIT Growth (5y)

12.09%

EBIT to Interest (avg)

-5.66

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.93

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.01%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.16

EV to EBIT

-80977.40

EV to EBITDA

-95113.88

EV to Capital Employed

11.62

EV to Sales

9650.56

PEG Ratio

Dividend Yield

ROCE (Latest)

-0.01%

ROE (Latest)

-0.00%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

OPERATING CASH FLOW(Y)

Highest at HKD 15,927.66 MM

ROCE(HY)

Highest at 8.52%

RAW MATERIAL COST(Y)

Fallen by -10.6% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 106.46%

NET SALES(Q)

Highest at HKD 37,906.84 MM

OPERATING PROFIT(Q)

Highest at HKD 2,414.04 MM

OPERATING PROFIT MARGIN(Q)

Highest at 6.37 %

PRE-TAX PROFIT(Q)

Highest at HKD 3,118.06 MM

NET PROFIT(Q)

Highest at HKD 2,788.97 MM

EPS(Q)

Highest at HKD 0.87

-1What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -79.14 %

Here's what is working for JD Health International, Inc.

Operating Cash Flow

Highest at HKD 15,927.66 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Net Sales

Highest at HKD 37,906.84 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit

Highest at HKD 2,414.04 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin

Highest at 6.37 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at HKD 3,118.06 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit

Highest at HKD 2,788.97 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS

Highest at HKD 0.87

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Debtors Turnover Ratio

Highest at 106.46%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -10.6% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at HKD 129.27 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 129.27 MM has Grown at 6.9%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for JD Health International, Inc.

Debt-Equity Ratio

Highest at -79.14 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio